HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenjie Huang Selected Research

beryl

7/2011Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenjie Huang Research Topics

Disease

32Neoplasms (Cancer)
06/2022 - 09/2012
20Neoplasm Metastasis (Metastasis)
09/2022 - 09/2012
17Hepatocellular Carcinoma (Hepatoma)
09/2022 - 11/2006
9Inflammation (Inflammations)
11/2022 - 05/2013
6Infections
01/2022 - 06/2012
6Carcinogenesis
04/2021 - 11/2006
5Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 03/2020
5Erectile Dysfunction
12/2021 - 04/2019
5Stomach Neoplasms (Stomach Cancer)
01/2021 - 11/2019
4Breast Neoplasms (Breast Cancer)
03/2021 - 03/2017
4Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 08/2016
4Virus Diseases (Viral Diseases)
11/2020 - 11/2006
3Nasopharyngeal Carcinoma
11/2022 - 03/2017
3Renal Cell Carcinoma (Grawitz Tumor)
03/2022 - 12/2020
3Fibrosis (Cirrhosis)
07/2021 - 11/2006
3Hypoxia (Hypoxemia)
01/2020 - 10/2015
3Wounds and Injuries (Trauma)
01/2020 - 01/2018
3Pneumonia (Pneumonitis)
01/2015 - 01/2013
2Asthma (Bronchial Asthma)
11/2022 - 01/2018
2Starvation
01/2022 - 01/2019
2COVID-19
01/2022 - 09/2020
2Autoimmune Diseases (Autoimmune Disease)
11/2021 - 03/2021
2Respiratory Insufficiency (Respiratory Failure)
02/2021 - 12/2018
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 10/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2021
2Sepsis (Septicemia)
12/2018 - 01/2013
2Berylliosis
10/2011 - 07/2011
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2021
1Atrophy
07/2021

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
09/2022 - 01/2017
14Proteins (Proteins, Gene)FDA Link
06/2022 - 11/2006
10MicroRNAs (MicroRNA)IBA
03/2022 - 01/2017
7Messenger RNA (mRNA)IBA
06/2022 - 06/2012
6Pharmaceutical PreparationsIBA
10/2022 - 10/2018
5Long Noncoding RNAIBA
09/2022 - 01/2020
5Biological ProductsIBA
09/2022 - 05/2013
4Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2018
3GemcitabineFDA Link
10/2022 - 03/2020
3LigandsIBA
01/2022 - 01/2019
3Circular RNAIBA
12/2021 - 01/2020
3Competitive Endogenous RNAIBA
01/2021 - 01/2020
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2013 - 11/2012
2ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2022
2lenvatinibIBA
02/2022 - 11/2021
2Chemokine ReceptorsIBA
01/2022 - 01/2021
23- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
01/2022 - 01/2021
2Insulin-Like PeptidesIBA
01/2022 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2021
2NF-kappa B (NF-kB)IBA
01/2022 - 03/2021
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2021 - 11/2021
28- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
11/2021 - 01/2021
2Sirolimus (Rapamycin)FDA Link
07/2021 - 01/2020
2rhodiolosideIBA
07/2021 - 01/2020
2Therapeutic UsesIBA
01/2021 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
2C-Reactive ProteinIBA
01/2021 - 12/2018
2Estrogens (Estrogen)FDA Link
01/2021 - 11/2017
2Fluorouracil (Carac)FDA LinkGeneric
11/2020 - 06/2020
2Connexin 43 (Connexin43)IBA
01/2020 - 04/2019
2Phosphotransferases (Kinase)IBA
12/2019 - 04/2017
2LipopolysaccharidesIBA
03/2017 - 01/2016
2SmokeIBA
01/2017 - 08/2016
2Forkhead Transcription Factors (Forkhead Box Proteins)IBA
10/2015 - 11/2012
2ChromatinIBA
03/2014 - 02/2013
2BerylliumIBA
10/2011 - 07/2011
1OvalbuminIBA
11/2022
1InflammasomesIBA
11/2022
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
10/2022
1SOX Transcription FactorsIBA
02/2022
1Lysine Acetyltransferase 5IBA
01/2022
1norsynephrine receptorIBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1Monomeric GTP-Binding ProteinsIBA
01/2022
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2022
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1P-2 (P 2)IBA
01/2022
1defactinibIBA
01/2022
1CXC ChemokinesIBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1TH 302IBA
01/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2022
1CholesterolIBA
01/2022
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022
1Blood Proteins (Serum Proteins)IBA
01/2022
1NSC 23766IBA
01/2022
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2021
1B7-H1 AntigenIBA
12/2021
1Macrophage Colony-Stimulating FactorIBA
12/2021
1PD 173074IBA
11/2021
1AntibodiesIBA
11/2021
1Immunoglobulin G (IgG)IBA
11/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
03/2021

Therapy/Procedure

13Therapeutics
11/2022 - 01/2019
4Drug Therapy (Chemotherapy)
10/2022 - 01/2020
4Immunotherapy
01/2022 - 01/2021
2Induction Chemotherapy
11/2022 - 01/2021
2Radiotherapy
01/2022 - 01/2022
2Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2020 - 11/2019